Bintai Kinden picks IEC to distribute Covid-19 vaccine in Australia, NZ


Covid-19 vaccine

KUALA LUMPUR: Bintai Kinden Corporation Bhd’s subsidiary has picked ASX-listed IEC Properties Pty Ltd as sole distributor for the Ii-Key-SARS-CoV-2 Covid-19 vaccine in Australia and New Zealand.

Bintai Healthcare Sdn Bhd had on Thursday signed an MoU with IEC – a unit of International Equities Corporation Ltd to further negotiate on the terms and conditions to grant IEC the exclusive distribution rights.

Subscribe now for a chance to win your dream holiday!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

AirAsia X launches first Africa route, targets 156,000 annual travellers
Nova Pharma gets National Institute of Biotechnology contract
Affin Bank, AHIBB establish commercial papers and MTN programmes
Southern Score gets RM315mil residential hi-rise development contract
PUC to dispose of software and IP for RM22mil
Ringgit ends marginally higher versus US dollar
Vitrox to build research facility in Penang
BNM requires ITO to offer MHIT products with cost-sharing features starting 3Q
TM secures RM1.25bil NG999 implementation contract
Steel Hawk signs underwriting agreement with UOB for upcoming transfer of listing

Others Also Read